ITGAE and neoplasm: Alongside the two classical cross-presenting populations that are CD8+XCR1+ and CD103+XCR1+ we have previously identified populations of LN-resident CD8−XCR1+ DCs and migratory CD103−XCR1+ DCs that are able to cross-present tumor antigen (38).